Page 2207 - Saunders Comprehensive Review For NCLEX-RN
P. 2207

3. Can cause rash, acne, anemia, thrombocytopenia, joint
                                                pain, diarrhea, and hypokalemia.
                                             4. Everolimus can cause mouth sores, infections,
                                                swelling and edema



                                                       Monitor the client taking an immunosuppressant closely for

                                                signs of infection.
                    III. Immunizations: See Chapter 18 for more information
                    IV. Antimicrobials (Box 63-3)
                                A. Inhibit the growth of bacteria
                                B. Include medication classifications of aminoglycosides,
                                   cephalosporins, fluoroquinolones, macrolides, lincosamides,
                                   monobactams, penicillins and penicillinase-resistant penicillins,
                                   sulfonamides, streptogramins, tetracyclines, antimycobacterials,
                                   and others (see Box 63-3)
                                C. Adverse effects (Table 63-1)

                                        D. Nursing considerations

                                             1. Assess for allergies.
                                             2. Monitor appropriate laboratory values before therapy
                                                as appropriate and during therapy to assess for
                                                adverse effects.
                                             3. Report adverse effects to the primary health care
                                                provider if any occur.
                                             4. Determine the appropriate method of administration
                                                and provide instructions to the client.
                                             5. Monitor intake and output.
                                             6. Encourage fluid intake (unless contraindicated).
                                             7. Initiate safety precautions because of possible central
                                                nervous system effects.
                                             8. Teach the client about the medication and how to take
                                                it; emphasize the importance of completing the full
                                                prescribed course.




               Box 63-1

               Medications for Human Immunodeficiency Virus
               (HIV) and Acquired Immunodeficiency Syndrome
               (AIDS)


               Nucleoside-Nucleotide Reverse Transcriptase Inhibitors (NRTIs)


                  ▪ Abacavir
                  ▪ Abacavir/lamivudine



                                                         2207
   2202   2203   2204   2205   2206   2207   2208   2209   2210   2211   2212